1. Trang chủ
  2. » Y Tế - Sức Khỏe

Chapter 125. Health Care– Associated Infections (Part 6) pot

4 260 0

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Nội dung

Chapter 125. Health Care– Associated Infections (Part 6) The epidemic of mad cow disease, centered in the United Kingdom, and associated human cases of variant Creutzfeldt-Jakob disease (Chap. 378) caused by disinfection-resistant prion agents have led to revised recommendations for decontaminating surgical instruments, especially those used for operations on the central nervous system or in patients with dementing illness of unknown etiology. The process of diagnosing and treating wound infections begins with a careful assessment of the surgical site in the febrile postoperative patient. Clinical findings range from obvious cellulitis or abscess formation to subtler clues such as a sternal "click" following open heart surgery. Diagnosis of deeper organ-space infections or subphrenic abscesses requires a high index of suspicion and the use of CT or MRI. Diagnosis of infections of prosthetic devices, such as orthopedic implants, may be particularly difficult and often requires the use of interventional radiographic techniques to obtain periprosthetic specimens for culture. The most common pathogens in postoperative wound infections are S. aureus, coagulase- negative staphylococci, and enteric and anaerobic bacteria. In rapidly progressing postoperative infections, which manifest within 24–48 h of a surgical procedure, the level of suspicion regarding group A streptococcal or clostridial infection (Chaps. 130 and 135) should be high. Treatment of postoperative wound infections requires drainage or surgical excision of infected or necrotic material and antibiotic therapy aimed at the most likely or laboratory-confirmed pathogens. Infections Related to Vascular Access and Monitoring Intravascular devices are common causes of local site infection and cause up to 50% of nosocomial bacteremias; central vascular catheters (CVCs) account for 80–90% of these infections. National estimates indicate that as many as 200,000 bloodstream infections associated with CVCs occur each year in the United States, with an attributable mortality of 12–25% and an estimated cost of $25,000 per episode; one-third to one-half of these episodes occur in ICUs. With increasing care of seriously ill patients in the community, vascular catheter– associated bloodstream infections acquired in outpatient settings may become as frequent as those acquired in hospitals. This possibility emphasizes the need to broaden surveillance activities. Catheter-related bloodstream infections derive largely from the cutaneous microflora of the insertion site, with pathogens migrating extraluminally to the catheter tip, usually during the first week after insertion. In addition, contamination of hubs of CVCs or of the ports of "needleless" systems may lead to intraluminal infection over longer periods, particularly with surgically implanted or cuffed catheters. Intrinsic contamination of infusate, although rare, is the most common cause of epidemic device-related bloodstream infection; extrinsic contamination may cause up to half of endemic bacteremias related to arterial infusions used for hemodynamic monitoring. The most common pathogens isolated from vascular device–associated bacteremias include coagulase-negative staphylococci, S. aureus (with up to 50% or more of isolates in the United States resistant to methicillin), enterococci, nosocomial gram-negative bacilli, and Candida. Many pathogens, especially staphylococci, produce extracellular polysaccharide biofilms that facilitate attachment to catheters and provide sanctuary from antimicrobial agents. "Quorum-sensing" proteins help bacterial cells communicate during biofilm development. Infections related to vascular catheters and monitoring devices may be the most preventable of nosocomial infections. Evidence-based bundles of control measures (Table 125-2) have been strikingly effective, eliminating all infections in one ICU study. Hospitals should periodically monitor adherence to these performance indicators. Use of antimicrobial- or antiseptic-impregnated CVCs does not appear necessary if the prevention bundle is fully implemented. Additional control measures for infections associated with vascular access include using a chlorhexidine-impregnated patch at the skin-catheter junction; avoiding the femoral site for catheterization because of higher risk of infection (most likely related to the density of the skin flora); moving peripheral catheters to a new site at specified intervals (e.g., every 72–96 h), which may be facilitated by use of an IV therapy team; and applying disposable transducers for pressure monitoring and aseptic technique for accessing transducers or other vascular ports. Improvements in composition of semitransparent access-site dressings and potential nursing benefits (ease of bathing and site inspection, protection of site from secretions) favor the use of such coverings. Unresolved issues include the best frequency for rotation of CVC sites (given that guidewire-assisted catheter changes at the same site do not lessen and may even increase infection risk); the appropriate role of mupirocin ointment, a topical antibiotic with excellent antistaphylococcal activity, in site care; the relative degrees of risk posed by peripherally inserted central catheters (PICC lines); and the risk-benefit of prophylactic use of heparin (to avoid catheter thrombi, which may be associated with increased risk of infection) or of vancomycin or alcohol (as catheter flushes or "locks"—i.e., concentrated anti- infective solutions instilled into the catheter lumen) for high-risk patients. . Chapter 125. Health Care– Associated Infections (Part 6) The epidemic of mad cow disease, centered in the United Kingdom, and associated human cases of variant. vascular catheters (CVCs) account for 80–90% of these infections. National estimates indicate that as many as 200,000 bloodstream infections associated with CVCs occur each year in the United. development. Infections related to vascular catheters and monitoring devices may be the most preventable of nosocomial infections. Evidence-based bundles of control measures (Table 125- 2) have

Ngày đăng: 07/07/2014, 15:20